ethylamine; deprotonated form | 54448-40-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: ethylamine; deprotonated form
• 英文别名: ethylaminide；Ethanamine, ion(1-)；ethylazanide
• CAS: 54448-40-7
• 化学式: C₂H₆N
• 分子量: 44.0763
• InChiKey: CKTNHGVJKUQEBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  3
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  六氟苯 、 ethylamine; deprotonated form 生成
  参考文献：
  名称：

  Ingemann, Steen; Nibbering, Nico M. M., Canadian Journal of Chemistry, 1984, vol. 62, p. 2273 - 2281

  摘要：

  DOI：

文献信息

• Tricyclic delta-opioid modulators
  申请人：Carson R. John

  公开号：US20050009860A1

  公开（公告）日：2005-01-13

  The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

  该发明涉及三环δ-阿片受体调节剂。更具体地，该发明涉及三环δ-阿片调节剂。还描述了使用该发明化合物的制药和兽医组合物以及治疗轻度至严重疼痛和各种疾病的方法。
• DI-, TRI-, and tetra-peptides having antiangiogenic activity
  申请人：——

  公开号：US20030109458A1

  公开（公告）日：2003-06-12

  Compounds having the formula (SEQ ID NO: 1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

  本文描述了具有公式（SEQ ID NO：1）的化合物，这些化合物对于治疗由血管生成引起或加重的疾病非常有用。此外，还披露了包含这些化合物的制药组合物，使用这些化合物进行治疗的方法以及抑制血管生成的方法。
• Di-, tri-, and tetra-peptides having antiangiogenic activity
  申请人：Haviv Fortuna

  公开号：US20050215484A1

  公开（公告）日：2005-09-29

  Compounds having the formula (SEQ ID NO: 1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

  本文描述了化学式为（SEQ ID NO：1）的化合物，这些化合物可用于治疗由血管生成引起或加剧的疾病。还披露了包含这些化合物的药物组合物、使用这些化合物进行治疗的方法以及抑制血管生成的方法。
• Propynyl or dienyl biaromatic compounds
  申请人：Centre International de Recherches Dermatologiques Galderma

  公开号：US06046220A1

  公开（公告）日：2000-04-04

  The invention relates to novel propynyl or dienyl biaromatic compounds which have the general formula (I) ##STR1## as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological complaints in particular), or alternatively in cosmetic compositions.

  本发明涉及新型丙炔基或二烯基双芳香化合物，其具有一般式(I) ##STR1##以及这些化合物在制备用于人类或兽医学（特别是皮肤病、风湿病、呼吸系统疾病、心血管疾病和眼科疾病）的药物组合物或化妆品组合物中的用途。
• Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
  申请人：Pfizer Inc.

  公开号：US07250518B2

  公开（公告）日：2007-07-31

  Compounds of the formula: useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils.

  分子式为：的化合物在抑制PDE4方面非常有用，可用于治疗由嗜酸性粒细胞的激活和脱颗粒调节的疾病。